Nexgel (NXGL) Other Non-Current Liabilities (2018 - 2024)
Nexgel posted quarterly Other Non-Current Liabilities of $178000.0 for Q4 2024, down 59.45% year-on-year from $439000.0 in Q1 2024, and down 34.32% on a QoQ basis from $271000.0 in Q3 2024.
Nexgel (NXGL) has 3 years of Other Non-Current Liabilities data on file, last reported at $178000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Liabilities fell 59.45% year-over-year to $178000.0; the trailing twelve-month figure through Dec 2024 stood at $178000.0 (down 59.45% YoY), and the FY2024 full-year result was $178000.0, down 59.45% from the prior year.
- Other Non-Current Liabilities for Q4 2024 stood at $178000.0, down from $271000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $439000.0 in Q4 2023 and bottomed at $178000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 271,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2018 | 51,000.00 |